Company Search:
Advanced Search
Sponsored Links
Banca Farmafactoring SpA Company Snapshot
Banca Farmafactoring SpA operates in the Misc. business credit institutions sector. In addition to historical fundamental analyses, the complete report available to purchase compares Banca Farmafactoring SpA with three other financial institutions in Europe: B2holding ASA of Norway (2018 sales of 2.82 billion Norwegian Kroner [US$306.66 million] ), Axactor SE of Sweden (2.13 billion Swedish Kronor [US$223.31 million] of which 41% was NPL), and Amigo Holdings PLC which is based in the United Kingdom (£210.80 million [US$273.77 million] of which 100% was Mortgage Loan).

Sales Analysis. Banca Farmafactoring SpA reported sales of 241.73 million Euro (US$267.99 million) for the year ending December of 2018. This represents a decrease of 0.1% versus 2017, when the company's sales were 242.03 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Banca Farmafactoring SpA
  Stock Performance Chart for Banca Farmafactoring SpA
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 5.46
(Figures in Euro)
1 Week 2.1%   13 Weeks -0.2%  
4 Weeks 18.4%   52 Weeks 18.2%  
Banca Farmafactoring SpA Key Data:
  Ticker: BFF Country: Italy
  Exchanges: ISE Major Industry: Diversified Financials
    Sub Industry: Misc. Business Credit Institutions
  2018 Sales 241,730,281
(Year Ending Jan 2019).
Employees: 452
  Currency: Euro Market Cap: 928,786,404
  Fiscal Yr Ends: December Shares Outstanding: 170,107,400
  Share Type: Azioni Ordinaire Closely Held Shares: 55,895,591
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.